Department of Ophthalmology, Hospital Clinico San Carlos, Madrid, Spain.
Cornea. 2010 Feb;29(2):167-71. doi: 10.1097/ICO.0b013e3181b11648.
To compare the effects of Viscofresh 0.5% (carmellose sodium 0. 5%) versus Lubristil (sodium hyaluronate 0.15%) in dry eye syndrome and to study the influence of these two treatments on the expression of various inflammatory markers by flow cytometry in impression cytology specimens.
In this randomized, masked-observer, parallel group, single-center study, 15 patients with dry eye syndrome were randomized to sodium carmellose 0.5% or sodium hyaluronate 0.15% 1-month treatment after a 1-week washout period. Corneal staining with flurescein, breakup time, Schirmer 1 test with anesthesia (Jones test), and tear clearance were assessed. Besides, conjunctival impression cytology was performed to investigate inflammatory markers (CD3, CD11b, and HLA-DR) using flow cytometry.
Carmellose group shows statistical improvement compared with the hyaluronate group in breakup time, corneal staining, and HLA-DR. The two other inflammatory markers had also a tendency for a decreased expression in both groups, with no statistical significance. There were neither visual acuity loss nor other complications related to treatment.
Both artificial tears improve dry eye signs and symptoms and inflammatory markers expression, with significant better results in carmellose group.
比较维可适 0.5%(卡波姆 0.5%)与丽眼达(透明质酸钠 0.15%)在干眼症中的疗效,并通过印迹细胞学研究这两种治疗方法对炎症标志物表达的影响。
这是一项随机、双盲、平行组、单中心研究,将 15 例干眼症患者在 1 周洗脱期后随机分为卡波姆 0.5%或透明质酸钠 0.15%组,进行为期 1 个月的治疗。评估角膜荧光素染色、泪膜破裂时间、麻醉(Jones 试验)下的 Schirmer 1 试验和泪液清除率。此外,通过印迹细胞学检查,采用流式细胞术研究炎症标志物(CD3、CD11b 和 HLA-DR)。
与透明质酸钠组相比,卡波姆组的泪膜破裂时间、角膜染色和 HLA-DR 均有统计学改善。另外两个炎症标志物在两组中的表达也有下降趋势,但无统计学意义。治疗过程中既没有视力丧失,也没有与治疗相关的其他并发症。
两种人工泪液均可改善干眼体征和症状及炎症标志物的表达,卡波姆组的效果更为显著。